Georgia HB1329: Controlled substances; Schedule I; provide certain provisions

What the bill says

To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to provide for certain provisions relating to Schedule I controlled substances; to provide for certain provisions relating to the definition of dangerous drugs; to provide for related matters; to provide for an effective date; to repeal conflicting laws; and for other purposes.

From the introduced text:

A BILL TO BE ENTITLED To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to provide for certain provisions relating to Schedule I controlled substances; to provide for certain provisions relating to the definition of dangerous drugs; to provide for related matters; to provide for an effective date; to repeal conflicting laws; and for other purposes. BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA: SECTION 1. Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, is amended in Code Section 16-13-25, relating to Schedule I controlled substances, by revising subparagraph (E) of paragraph (16) as follows: "(E) By substitution at the 5-position or 6-position with a nitro, alkyl, halide, cyano, or acetyl group or primary amine;" SECTION 2. Said chapter is further amended in Code Section 16-13-71, relating to dangerous drug, by adding new paragraphs to subsection (b) to read as follows: H. B. 1329 LC 65 0071 "(1.5) Aceclidine;" "(12.7) Acoltremon;" "(17.2) Aficamten;" "(68.45) Atrasentan;" "(69.21) Avutometinib;" "(91.71) Berahyaluronidase alfa-pmph;" "(106.4) Brensocatib;" "(196.3) Clesrovimab-cfor;" "(240.97) Datopotamab deruxtecan-dlnk;" "(243.4) Defactinib;" "(244.7) Delgocitinib;" "(248.5) Depemokimab-ulaa;" "(316.6) Donidalorsen;" "(317.15) Dordaviprone;" "(318.7) Doxecitine;" "(320.5) Doxribtimine;" "(331.0513) Elamipretide;" "(331.0555) Elinzanetant;" "(379.8) Etripamil;" "(386.95) Fitusiran;" "(411.9) Garadacimab-gxii;" "(414.4) Gepotidacin;" "(466.7) Imlunestrant;" "(513.75) Lerodalcibep-liga;" "(523.5) Linvoseltamab-gcpt;" "(619.15) …

Read the full official text

Sponsors

• Ben Watson (R, SD-001) · primary sponsor
• Ron Stephens (R, 164) · primary sponsor
• Mark Newton (R, 127)

Latest actions

1. May 5, 2026: Act 390
2. May 5, 2026: Effective Date
3. May 5, 2026: House Date Signed by Governor
4. April 6, 2026: House Sent to Governor
5. March 20, 2026: Senate Passed/Adopted
6. March 20, 2026: Senate Third Read
7. March 19, 2026: Senate Read Second Time
8. March 18, 2026: Senate Committee Favorably Reported
9. February 26, 2026: Senate Read and Referred
10. February 25, 2026: House Passed/Adopted

Votes

• Senate Vote #779 (March 20, 2026): 41 yea, 0 nay, passed
• House Vote #561 (February 25, 2026): 171 yea, 0 nay, passed

Common questions

What is HB1329?

HB1329 is a bill in the Georgia Legislature (2025-2026 Regular Session): Controlled substances; Schedule I; provide certain provisions.

What does HB1329 do?

In its own words: To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to provide for certain provisions relating to Schedule I controlled substances; to provide for certain provisions relating to the definition of dangerous drugs; to provide for related matters; to provide for an effective date; to repeal conflicting laws; and for other purposes.

What is the status of HB1329?

Signed into law as of May 5, 2026. Latest action: Act 390 (May 5, 2026).

Who sponsored HB1329?

Ben Watson (R, SD-001), with 2 co-sponsors.

Where is the official record for HB1329?

On the Georgia Legislature website: https://www.legis.ga.gov/legislation/73260